We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

FLOW-Finding Lasting Options for Women

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00397202
Recruitment Status : Completed
First Posted : November 8, 2006
Last Update Posted : April 30, 2015
Information provided by (Responsible Party):

Study Description
Brief Summary:
  1. Purpose: To compare the use of the menstrual cup "The DivaCupTM " to a menstrual strategy using tampons as the primary method of menstrual flow management using indicators of user-satisfaction, urinary tract infection, vaginal irritation, cost and waste.
  2. Hypothesis: The "The DivaCupTM" will have similar rates of user-satisfaction, urinary tract infection, and vaginal irritation as a menstrual strategy using tampons as the primary method of menstrual flow management but will likely be more reasonable in terms of cost and will generate less waste.

Condition or disease Intervention/treatment
Menstruation Device: Diva Cup TM

Detailed Description:


Prospective study of 100 women from family practice offices in Vancouver, Victoria and Prince George who currently use tampons to manage menstrual flow. After an information session and consent, subjects will be randomized to tampon use or Diva Cup use and record their experience on a diary for 3 months. Women who attend the information session and who do not enrol, or those who drop out will be asked their reasons for discontinuing, and their pre-study questionnaire will be used for analysis.

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 110 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Official Title: FLOW-Finding Lasting Options for Women: A Prospective, Randomized, Multicenter Trial Comparing Tampons to a Menstrual Cup
Study Start Date : November 2006
Primary Completion Date : June 2009
Study Completion Date : June 2011

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Menstruation
U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
Active Comparator: The DivaCupTM Device: Diva Cup TM
See Detailed Description.

Outcome Measures

Primary Outcome Measures :
  1. Overall satisfaction with menstrual strategy.

Secondary Outcome Measures :
  1. Diagnosed UTI
  2. Diagnosed vaginitis
  3. Vaginal irritation
  4. Waste
  5. Cost

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   19 Years to 40 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Women between the ages of 19 and 40 who have menstrual flow most months and who currently self-identify as using tampons as their primary method of menstrual management

Exclusion Criteria:

  • Have a sensitivity or allergy to silicone
  • Have an active vaginal or urogenital infection
  • Are pregnant, or who have plans to become pregnant before spring 2007 (end of study data collection)
  • Have used systemic antimicrobials within the previous 14 days
  • Are unable to understand the nature and purpose of the study
  • Are unable to understand and express themselves in written and spoken English
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00397202

Canada, British Columbia
Private family physician offices
Victoria, Vancouver, Prince George, British Columbia, Canada
Sponsors and Collaborators
University of British Columbia
National Research System-College of Family Physicians of Canada
Principal Investigator: Konia Trouton, MD University of British Columbia
More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: University of British Columbia
ClinicalTrials.gov Identifier: NCT00397202     History of Changes
Other Study ID Numbers: H06-70478
First Posted: November 8, 2006    Key Record Dates
Last Update Posted: April 30, 2015
Last Verified: April 2015

Keywords provided by University of British Columbia: